Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sjögren's syndrome: a randomised, double-blind, placebo-controlled, phase 2b dose-finding trial

Simon Bowman, Robert Fox, Thomas Dörner, Xavier Mariette, Athena Papas, Thomas Grader-Beck, Benjamin Fisher, Filipe Barcelos, Salvatore De Vita, Hendrik Schulze-Koops, Robert Moots, Guido Junge, Janice Woznicki, Monika Sopala, Wen-Lin Luo, Wolfgang Hueber

Research output: Contribution to journal › Article › peer-review

552 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sjögren's syndrome: a randomised, double-blind, placebo-controlled, phase 2b dose-finding trial'. Together they form a unique fingerprint.

Medicine & Life Sciences